Arvinas (ARVN) Common Equity (2017 - 2026)

Arvinas' (ARVN) quarterly Common Equity came in at $386.8 million in Q1 2026, down 41.4% year-on-year from $660.1 million in Q1 2025, and down 10.86% quarter-over-quarter from $433.9 million in Q4 2025.

Arvinas (ARVN) Common Equity (2017 - 2026) Analysis & Trends

Arvinas' Common Equity history runs 10 years deep, the most recent figure standing at $386.8 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 41.4% year-over-year to $386.8 million in Q1 2026; TTM through Mar 2026 was $386.8 million, a 41.4% decrease from a year earlier, with the FY2025 full-year figure at $433.9 million, down 22.75% from the prior year.
  • Common Equity retreated to $386.8 million in Q1 2026 per ARVN's latest filing, from $433.9 million in the prior quarter.
  • Across five years, Common Equity topped out at $723.3 million in Q1 2022 and bottomed at $386.8 million in Q1 2026.
  • The 5-year median for Common Equity is $586.0 million (2024), against an average of $569.7 million.
  • Across the five-year window, Common Equity increased 29.47% in 2024 and plunged 41.4% in 2026, its largest moves.
  • Year by year, Common Equity stood at $564.9 million in 2022, then rose by 16.83% to $660.0 million in 2023, then retreated by 14.89% to $561.7 million in 2024, then fell by 22.75% to $433.9 million in 2025, then dropped by 10.86% to $386.8 million in 2026.
  • Per Business Quant, the three latest ARVN Common Equity figures stand at $386.8 million (Q1 2026), $433.9 million (Q4 2025), and $564.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 251.12 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -98.34 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 14.38 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 4.76 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 795.79 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.50 Bn
10 Arvinas 512.64 Mn -102.26 Mn - 386.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 386.80 Mn
Dec 31, 2025 433.90 Mn
Sep 30, 2025 564.40 Mn
Jun 30, 2025 609.30 Mn
Mar 31, 2025 660.10 Mn
Dec 31, 2024 561.70 Mn
Sep 30, 2024 586.00 Mn
Jun 30, 2024 600.20 Mn
Mar 31, 2024 609.70 Mn
Dec 31, 2023 660.00 Mn
Sep 30, 2023 457.20 Mn
Jun 30, 2023 463.60 Mn
Mar 31, 2023 511.00 Mn
Dec 31, 2022 564.90 Mn
Sep 30, 2022 621.50 Mn
Jun 30, 2022 670.60 Mn
Mar 31, 2022 723.30 Mn
Dec 31, 2021 781.70 Mn
Sep 30, 2021 817.70 Mn
Jun 30, 2021 582.90 Mn